Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.17
SPNC's Cash-to-Debt is ranked lower than
91% of the 331 Companies
in the Global Medical Devices industry.

( Industry Median: 2.87 vs. SPNC: 0.17 )
Ranked among companies with meaningful Cash-to-Debt only.
SPNC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.14  Med: 37.92 Max: No Debt
Current: 0.17
Equity-to-Asset 0.10
SPNC's Equity-to-Asset is ranked lower than
94% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. SPNC: 0.10 )
Ranked among companies with meaningful Equity-to-Asset only.
SPNC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.1  Med: 0.76 Max: 0.94
Current: 0.1
0.1
0.94
Debt-to-Equity 8.25
SPNC's Debt-to-Equity is ranked lower than
100% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 0.27 vs. SPNC: 8.25 )
Ranked among companies with meaningful Debt-to-Equity only.
SPNC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0  Med: 0.05 Max: 8.25
Current: 8.25
0
8.25
Debt-to-EBITDA -12.55
SPNC's Debt-to-EBITDA is ranked lower than
99.99% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. SPNC: -12.55 )
Ranked among companies with meaningful Debt-to-EBITDA only.
SPNC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -18.63  Med: -12.67 Max: -10.96
Current: -12.55
-18.63
-10.96
Piotroski F-Score: 3
Altman Z-Score: 2.07
Beneish M-Score: -2.80
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % -19.22
SPNC's Operating Margin % is ranked lower than
67% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. SPNC: -19.22 )
Ranked among companies with meaningful Operating Margin % only.
SPNC' s Operating Margin % Range Over the Past 10 Years
Min: -20.54  Med: -6.01 Max: 2.1
Current: -19.22
-20.54
2.1
Net Margin % -24.26
SPNC's Net Margin % is ranked lower than
67% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 1.62 vs. SPNC: -24.26 )
Ranked among companies with meaningful Net Margin % only.
SPNC' s Net Margin % Range Over the Past 10 Years
Min: -24.18  Med: -7.44 Max: 8.72
Current: -24.26
-24.18
8.72
ROE % -98.89
SPNC's ROE % is ranked lower than
87% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.53 vs. SPNC: -98.89 )
Ranked among companies with meaningful ROE % only.
SPNC' s ROE % Range Over the Past 10 Years
Min: -60.77  Med: -9.77 Max: 8.5
Current: -98.89
-60.77
8.5
ROA % -16.06
SPNC's ROA % is ranked lower than
66% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.11 vs. SPNC: -16.06 )
Ranked among companies with meaningful ROA % only.
SPNC' s ROA % Range Over the Past 10 Years
Min: -13.44  Med: -7.9 Max: 7.25
Current: -16.06
-13.44
7.25
ROC (Joel Greenblatt) % -66.66
SPNC's ROC (Joel Greenblatt) % is ranked lower than
67% of the 326 Companies
in the Global Medical Devices industry.

( Industry Median: 4.41 vs. SPNC: -66.66 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SPNC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -69.69  Med: -16.46 Max: 8.69
Current: -66.66
-69.69
8.69
3-Year Revenue Growth Rate 15.70
SPNC's 3-Year Revenue Growth Rate is ranked higher than
78% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. SPNC: 15.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SPNC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -6  Med: 7.35 Max: 32.3
Current: 15.7
-6
32.3
3-Year EPS without NRI Growth Rate 413.00
SPNC's 3-Year EPS without NRI Growth Rate is ranked higher than
100% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 1.70 vs. SPNC: 413.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SPNC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -70.5  Med: 10.05 Max: 413
Current: 413
-70.5
413
GuruFocus has detected 7 Warning Signs with The Spectranetics Corp SPNC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SPNC's 30-Y Financials

Financials (Next Earnings Date: 2017-10-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

SPNC Guru Trades in Q3 2016

Jim Simons 32,222 sh (New)
Paul Tudor Jones 14,550 sh (New)
Ron Baron 1,528,500 sh (-13.77%)
Steven Cohen 129,900 sh (-53.07%)
» More
Q4 2016

SPNC Guru Trades in Q4 2016

John Hussman 140,000 sh (New)
Ron Baron 1,540,500 sh (+0.79%)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Steven Cohen 24,900 sh (-80.83%)
» More
Q1 2017

SPNC Guru Trades in Q1 2017

Jim Simons 61,922 sh (New)
Steven Cohen 205,667 sh (+725.97%)
John Hussman Sold Out
Ron Baron 1,301,500 sh (-15.51%)
» More
Q2 2017

SPNC Guru Trades in Q2 2017

John Paulson 237,500 sh (New)
Leucadia National 130,000 sh (New)
Mario Gabelli 348,650 sh (New)
Ron Baron 1,356,500 sh (+4.23%)
Jim Simons Sold Out
Steven Cohen 23,400 sh (-88.62%)
» More
» Details

Insider Trades

Latest Guru Trades with SPNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2017-06-30 Add 4.23%0.01%$26.35 - $38.35 $ 38.4534%1,356,500
Mario Gabelli 2017-06-30 New Buy0.09%$26.35 - $38.35 $ 38.4534%348,650
John Paulson 2017-06-30 New Buy0.12%$26.35 - $38.35 $ 38.4534%237,500
Leucadia National 2017-06-30 New Buy0.43%$26.35 - $38.35 $ 38.4534%130,000
Ron Baron 2017-03-31 Reduce -15.51%0.03%$24.25 - $29.13 $ 38.4544%1,301,500
Ron Baron 2016-12-31 Add 0.79%$20.85 - $25.14 $ 38.4563%1,540,500
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:XTER:DRW3, NYSE:ITGR, TSE:3360, TSE:7575, TSE:6849, SZSE:300633, NAS:CNMD, XSWX:YPSN, SZSE:002317, OCSE:OSSR, NAS:MDXG, HKSE:00853, SZSE:300529, NAS:INGN, SZSE:300216, SZSE:300298, SZSE:000607, NAS:BABY, SZSE:300273, SHSE:603579 » details
Traded in other countries:SC7.Germany,
Headquarter Location:USA
The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads.

Spectranetics manufactures and sells single-use medical devices used in minimally invasive cardiovascular procedures. The firm operates in the three categories: vascular intervention, lead management, and laser, service, and other. The vascular intervention business contributes the majority of revenue and sells laser and aspiration catheters, balloon catheters, and support catheters. The lead management business sells devices used to remove pacemaker and defibrillator cardiac leads. The laser, service, and other business includes a laser system for cardiovascular procedures. Spectranetics generates the vast majority of its revenue in the United States.

Ratios

vs
industry
vs
history
PB Ratio 40.95
SPNC's PB Ratio is ranked lower than
98% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. SPNC: 40.95 )
Ranked among companies with meaningful PB Ratio only.
SPNC' s PB Ratio Range Over the Past 10 Years
Min: 0.78  Med: 4.4 Max: 41
Current: 40.95
0.78
41
PS Ratio 5.86
SPNC's PS Ratio is ranked lower than
72% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. SPNC: 5.86 )
Ranked among companies with meaningful PS Ratio only.
SPNC' s PS Ratio Range Over the Past 10 Years
Min: 0.69  Med: 3.47 Max: 7.92
Current: 5.86
0.69
7.92
EV-to-EBIT -36.36
SPNC's EV-to-EBIT is ranked lower than
99.99% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 23.37 vs. SPNC: -36.36 )
Ranked among companies with meaningful EV-to-EBIT only.
SPNC' s EV-to-EBIT Range Over the Past 10 Years
Min: -4632.7  Med: -17.3 Max: 2801.8
Current: -36.36
-4632.7
2801.8
EV-to-EBITDA -72.97
SPNC's EV-to-EBITDA is ranked lower than
99.99% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 17.75 vs. SPNC: -72.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
SPNC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -371.8  Med: 21.2 Max: 9534.2
Current: -72.97
-371.8
9534.2
EV-to-Revenue 6.94
SPNC's EV-to-Revenue is ranked lower than
73% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 3.38 vs. SPNC: 6.94 )
Ranked among companies with meaningful EV-to-Revenue only.
SPNC' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5  Med: 3.6 Max: 8.2
Current: 6.94
0.5
8.2
Current Ratio 1.92
SPNC's Current Ratio is ranked lower than
66% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. SPNC: 1.92 )
Ranked among companies with meaningful Current Ratio only.
SPNC' s Current Ratio Range Over the Past 10 Years
Min: 1.4  Med: 2.7 Max: 17.73
Current: 1.92
1.4
17.73
Quick Ratio 1.52
SPNC's Quick Ratio is ranked lower than
62% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. SPNC: 1.52 )
Ranked among companies with meaningful Quick Ratio only.
SPNC' s Quick Ratio Range Over the Past 10 Years
Min: 1.2  Med: 2.35 Max: 16.5
Current: 1.52
1.2
16.5
Days Inventory 140.77
SPNC's Days Inventory is ranked lower than
51% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 139.39 vs. SPNC: 140.77 )
Ranked among companies with meaningful Days Inventory only.
SPNC' s Days Inventory Range Over the Past 10 Years
Min: 82.8  Med: 89.76 Max: 146.27
Current: 140.77
82.8
146.27
Days Sales Outstanding 60.84
SPNC's Days Sales Outstanding is ranked higher than
61% of the 277 Companies
in the Global Medical Devices industry.

( Industry Median: 67.97 vs. SPNC: 60.84 )
Ranked among companies with meaningful Days Sales Outstanding only.
SPNC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 48.49  Med: 56.65 Max: 73.19
Current: 60.84
48.49
73.19
Days Payable 33.23
SPNC's Days Payable is ranked lower than
75% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. SPNC: 33.23 )
Ranked among companies with meaningful Days Payable only.
SPNC' s Days Payable Range Over the Past 10 Years
Min: 14.31  Med: 21.02 Max: 33.28
Current: 33.23
14.31
33.28

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.60
SPNC's 3-Year Average Share Buyback Ratio is ranked higher than
68% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: -4.90 vs. SPNC: -1.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SPNC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40.2  Med: -6.9 Max: -0.8
Current: -1.6
-40.2
-0.8

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 1.68
SPNC's Price-to-Median-PS-Value is ranked lower than
79% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. SPNC: 1.68 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SPNC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.18  Med: 1.05 Max: 5.39
Current: 1.68
0.18
5.39
Earnings Yield (Greenblatt) % -2.75
SPNC's Earnings Yield (Greenblatt) % is ranked lower than
62% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.94 vs. SPNC: -2.75 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SPNC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -14.5  Med: -2.4 Max: 31.1
Current: -2.75
-14.5
31.1

More Statistics

Revenue (TTM) (Mil) $284.59
EPS (TTM) $ -1.59
Short Percentage of Float10.57%
52-Week Range $19.80 - 38.55
Shares Outstanding (Mil)44.05

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 302 364 462
EPS ($) -1.15 -0.74 -0.13
EPS without NRI ($) -1.15 -0.74 -0.13
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 33
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}